Wedge Capital Management L L P NC grew its holdings in shares of Thermo Fisher Scientific Inc. (NYSE:TMO – Free Report) by ...
Roche plans to release the system in the US to run tests including vitamin D and steroid assays under CLIA before it possibly receives US Food and Drug Administration clearance.
Thermo Fisher Scientific (TMO) offers growth potential with diverse revenue streams, fair valuation, and strong CAGR ...
The global Oligonucleotide CDMO Market, valued at US$2.33 billion in 2023, is forecasted to grow at a robust CAGR of 21.8%, ...
In a pioneering experiment, a robotic sample preparation platform, driven by artificial intelligence (AI) was used to ...